Marx Biotechnology was awarded and has received funding from the European Union’s Horizon 2020 first stage research and innovation program under grant agreement No 877774 dated Sept 2019
This project has received funding from the European Union’s Horizon 2020 research and innovation program under grant agreement No 877774
